These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2015573)

  • 1. Cytokine biology. Implications for transfusion medicine.
    Adamson JW
    Cancer; 1991 May; 67(10 Suppl):2708-11. PubMed ID: 2015573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of recombinant erythropoietin in anemic patients with cancer.
    Spivak JL
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):25-8. PubMed ID: 1615336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia of prematurity: progress and prospects.
    Shannon KM
    Am J Pediatr Hematol Oncol; 1990; 12(1):14-20. PubMed ID: 2178457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
    Erslev AJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
    Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y
    Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of care in the management of anemia.
    Henry DH
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):3-7. PubMed ID: 1615338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1990; 12(1):1-3. PubMed ID: 2178456
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin (r-HuEPO) increases total bilirubin production in premature infants.
    Baxter LM; Vreman HJ; Ball B; Stevenson DK
    Clin Pediatr (Phila); 1995 Apr; 34(4):213-6. PubMed ID: 7789015
    [No Abstract]   [Full Text] [Related]  

  • 17. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
    Abels RI
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin in anemia of prematurity.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):80-4. PubMed ID: 23025776
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia.
    Griggs JJ; Blumberg N
    Anticancer Drugs; 1998 Nov; 9(10):925-32. PubMed ID: 9890704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.